Onassis Cardiac Surgery Centre
10
2
4
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation
Role: collaborator
Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data
Role: collaborator
Correlation of Typical LBBB Mechanical Activation Pattern by 2D Strain Echocardiography With Acute GWE Improvement in Patients Receiving LBBp or Conventional BiVp for Cardiac Resynchronization Therapy (Echo LBBp)
Role: collaborator
Prevention and Treatment of AKI VEXUS Guided Post Cardiac Surgery
Role: lead
Prognostic Indices of Atheromatosis Severity and Coronary Artery Bypass Surgery Outcomes for Patients With Coronary Artery Disease
Role: lead
Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study
Role: collaborator
Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure
Role: lead
Captopril Versus Atenolol to Prevent Expansion Rate of Thoracic Aortic Aneurysms
Role: lead
The SOS (Stenting Of Saphenous Vein Grafts) Trial
Role: collaborator
Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention
Role: lead
All 10 trials loaded